Showing 91 - 100 of 286
Persistent link: https://www.econbiz.de/10005172790
A question of significant interest in female reproductive aging is to identify bleeding criteria for the menopausal transition. Although various bleeding criteria, or markers, have been proposed for the menopausal transition, their validity has not been adequately examined. The Tremin Trust data...
Persistent link: https://www.econbiz.de/10005750993
Randomized allocation of treatments is a cornerstone of experimental design, but has drawbacks when a limited set of individuals are willing to be randomized, or the act of randomization undermines the success of the treatment. Choice-based experimental designs allow a subset of the participants...
Persistent link: https://www.econbiz.de/10005579276
Persistent link: https://www.econbiz.de/10010684018
Although the randomized, controlled trial (RCT) is considered the gold standard in research for determining the efficacy of health education interventions, such trials may be vulnerable to "preference effects"; that is, differential outcomes depending on whether an individual is randomized to...
Persistent link: https://www.econbiz.de/10008613400
The objective of this paper is to quantify the effect of correlation in false discovery rate analysis. Specifically, we derive approximations for the mean, variance, distribution and quantiles of the standard false discovery rate estimator for arbitrarily correlated data. This is achieved using...
Persistent link: https://www.econbiz.de/10009148396
In the analysis of bivariate correlated failure time data, it is important to measure the strength of association among the correlated failure times. One commonly used measure is the cross ratio. Motivated by Cox's partial likelihood idea, we propose a novel parametric cross ratio estimator that...
Persistent link: https://www.econbiz.de/10009148402
Persistent link: https://www.econbiz.de/10008784043
Data analysis for randomized trials including multitreatment arms is often complicated by subjects who do not comply with their treatment assignment. We discuss here methods of estimating treatment efficacy for randomized trials involving multitreatment arms subject to non-compliance. One...
Persistent link: https://www.econbiz.de/10008671166
Persistent link: https://www.econbiz.de/10011036020